raloxifene hydrochloride has been researched along with Polyarthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enokida, M; Hagino, H; Hayashi, I; Okano, T; Teshima, R | 1 |
| Labovitz, JM; Revill, K | 1 |
| Carlsten, H; Islander, U; Jochems, C; Kallkopf, A; Lagerquist, M; Ohlsson, C | 1 |
1 review(s) available for raloxifene hydrochloride and Polyarthritis
| Article | Year |
|---|---|
Osteoporosis: pathogenesis, new therapies and surgical implications.
Topics: Arthritis; Autoimmune Diseases; Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Humans; Osteoporosis; Raloxifene Hydrochloride; Surgical Procedures, Operative | 2007 |
2 other study(ies) available for raloxifene hydrochloride and Polyarthritis
| Article | Year |
|---|---|
Effect of raloxifene on arthritis and bone mineral density in rats with collagen-induced arthritis.
Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Female; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley | 2011 |
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Cytokines; Female; Humans; Mice; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |